OBJECTIVES: To evaluate the safety, feasibility, and efficacy of a substitutive Hospital at Home (HaH) model where physician care was provided via 2-way biometrically enhanced tele-video for a 34-day care episode. STUDY DESIGN: Prospective, nonrandomized, quasi-experiment. METHODS: Using medical record and patient survey data, we compared patients cared for in HaH (n = 50) versus the traditional acute care hospital (n = 52). RESULTS: Patients in HaH had substantial contact with the HaH physician, as well as in-person visits with nurse practitioners and other care providers. HaH patients were more satisfied with their care in multiple domains and met illness-specific quality standards at similar rates to hospital comparison patients. Functional outcomes were notable for a trend toward improvements in activities of daily living among HaH patients. Compared with hospital patients at 90 days after discharge, HaH patients were less likely to experience a hospital readmission (adjusted odds ratio, 0.39; 95% CI, 0.21-0.72). CONCLUSIONS: This pilot study suggests that a scalable substitutive model of HaH using biometrically enhanced 2-way tele-video, virtual physician visits, and caring for patients over a 34-day episode is safe, feasible, highly satisfactory, and may be associated with substantial reductions in hospital readmissions.
OBJECTIVES: To evaluate the safety, feasibility, and efficacy of a substitutive Hospital at Home (HaH) model where physician care was provided via 2-way biometrically enhanced tele-video for a 34-day care episode. STUDY DESIGN: Prospective, nonrandomized, quasi-experiment. METHODS: Using medical record and patient survey data, we compared patients cared for in HaH (n = 50) versus the traditional acute care hospital (n = 52). RESULTS:Patients in HaH had substantial contact with the HaH physician, as well as in-person visits with nurse practitioners and other care providers. HaH patients were more satisfied with their care in multiple domains and met illness-specific quality standards at similar rates to hospital comparison patients. Functional outcomes were notable for a trend toward improvements in activities of daily living among HaH patients. Compared with hospital patients at 90 days after discharge, HaH patients were less likely to experience a hospital readmission (adjusted odds ratio, 0.39; 95% CI, 0.21-0.72). CONCLUSIONS: This pilot study suggests that a scalable substitutive model of HaH using biometrically enhanced 2-way tele-video, virtual physician visits, and caring for patients over a 34-day episode is safe, feasible, highly satisfactory, and may be associated with substantial reductions in hospital readmissions.
Authors: Pamela M Saenger; Katherine A Ornstein; Melissa M Garrido; Sara Lubetsky; Evan Bollens-Lund; Linda V DeCherrie; Bruce Leff; Albert L Siu; Alex D Federman Journal: J Am Geriatr Soc Date: 2022-02-25 Impact factor: 7.538
Authors: Ryan D Nipp; Eliza Shulman; Melissa Smith; Patricia M C Brown; P Connor Johnson; Eva Gaufberg; Charu Vyas; Carolyn L Qian; Isabel Neckermann; Shira B Hornstein; Mathew J Reynolds; Joseph Greer; Jennifer S Temel; Areej El-Jawahri Journal: BMC Cancer Date: 2022-04-09 Impact factor: 4.430
Authors: Xiaoxi Yao; Margaret Paulson; Michael J Maniaci; Ajani N Dunn; Chad R Nelson; Emma M Behnken; Melissa S Hart; Lindsey R Sangaralingham; Shealeigh A Inselman; Michelle A Lampman; Shannon M Dunlay; Sean C Dowdy; Elizabeth B Habermann Journal: Trials Date: 2022-06-16 Impact factor: 2.728